| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |